effect of two diffrent doses of drug dexmedetomidine on stress response which is measured by blood pressure heart rate and blood test like cortiol and sugar in patients undergoing laproscopic pyeloplasty surgery.

Effect of two different doses of dexmedetomidine on stress response in laproscopic pyeloplasty; a randomised prospective controlled study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/08/003892

Enrollment

Registered

2013-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- laproscopic pyeloplasty surgery

Interventions

Intervention1: dexmedetomidine: dexmedetomidine 1 ug/kg BW loading and .7 ug/KG BW Intervention2: dexmedetomidine: maintainance,dexmedetomidine .7 ug/KG BW loading and .5ug/KG BW maintainance, Control

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II

Exclusion criteria

Exclusion criteria: -Patients with ASA Gr III and IV -Patients on steroid therapy - -Anticipated difficult airway e.g. mallampati III,IV -Patients with compromised cardiac functions -Anticoagulent used within preceding 4 weeks -Laparoscopic procedure converted to laparotomy

Design outcomes

Primary

Measure	Time frame
reduced stress responceTimepoint: 1	—

Secondary

Measure	Time frame
effect on renal outcomeTimepoint: 1	—

Countries

India

Contacts

Public Contactdr shashi srivastava

sanjai gandhi post garaduate institute

shamim.shamim15@gmail.com8004967759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026